Literature DB >> 27642404

Breast cancer patients' presentation for oncological treatment: a single centre study.

Akinbolaji Andrew Akinkuolie1, Amarachukwu Chiduziem Etonyeaku1, Olalekan Olasehinde1, Olukayode Adeolu Arowolo1, Rereloluwa Nicodemus Babalola2.   

Abstract

INTRODUCTION: Breast cancer patients are presenting at advanced stages for oncological treatment in Nigeria and World Health Organization predicted developing countries' breast cancer incidence and mortality to increase by year 2020.
METHODS: Prospective observational hospital based study that enrolled breast cancer patients from catchment area of an oncology service hospital in Nigeria between 2007 and 2013. Patients' demographics, breast cancer burden and health care giver presentation variables were analysed for causal factors of seeking medical help and what determines commencement of effective oncological treatment.
RESULTS: Forty-six patients were enrolled, 19.6% of them presented primarily to oncologist while 80.4% presented secondarily for oncological treatment. There is a significant difference in presentation time for oncological treatment (t = -3.56, df = 42.90, p = 0.001) between primary (M =11.56 ± 5.21 weeks) and secondary presentation (M= 52.56 ± 10.27weeks). Tumor burden of those that presented secondarily were significantly more advanced (U = 78.5, p = 0.011) and, univariate analysis reveals that: patients' matrimonial setting, breast cancer awareness and mode of discovery of breast symptoms are patient related factors that determines their choice of health care providers and, determinant of effective oncological treatment is patient first contact health care provider.
CONCLUSION: Patients' bio-characteristics that determine their choice of health care provider should be incorporated into community breast cancer sensitization drives. Additionally, there is a need for a government agency assign the task of accrediting and defining scope of enterprise of health care institutions and their health care providers in our pluralist health system.

Entities:  

Keywords:  Breast cancer; oncological treatment; presentation

Mesh:

Year:  2016        PMID: 27642404      PMCID: PMC5012757          DOI: 10.11604/pamj.2016.24.63.8432

Source DB:  PubMed          Journal:  Pan Afr Med J


Introduction

Breast cancer is the commonest cancer among women worldwide and the most common cause of cancer related morbidity and mortality [1-3]. There is marked geographical variation in morbidity and mortality of breast cancer between the developed and developing countries [4-7]. Breast cancer screening and early presentation has changed the dismal outcome of this disease in the developed countries where despite increasing incidence, the morbidity and mortality are declining [4, 8]. However, the contrary is true in developing countries especially Nigeria where despite alarming increase in incidence, about 70 - 80% of breast cancer patients are still presenting with locally advanced or metastatic breast cancer [9-12]. More worrisome is the World Health Organization (WHO) report that expects world breast cancer incidence and mortality to increase by 50% by 2020 and this increase is anticipated to be highest in the developing countries of which Nigeria is inclusive: where 55% increase in incidence and 58% increase in mortality is predicted [13, 14]. In preparing for this anticipated increase, priority in developing countries should be to formulate breast cancer control strategies such as early breast cancer detection and early presentation for effective oncological treatment [15, 16]. The objective of this study is to find out patients’ related factors promoting early presentation and causal factor(s) of effective oncological treatment with the aim of reducing breast cancer related morbidity and mortality.

Methods

This is a cross-sectional hospital based study carried out at Wesley Guild Hospital (WGH) in Ilesa, between January 2007 and December 2013. Ilesa is a cosmopolitan town situated in Osun States in south western Nigeria. The town has good roads network connection and transport system, it health system is pluralist made up of orthodox and modern health facilities and the modern health facilities consist of private and government owned hospitals. WGH is one of the governments owned hospital and is a satellite hospital of Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife, Nigeria. Eligibility for the study is being a breast cancer patient presenting at the surgical oncology unit of WGH consenting to recruitment and data collected to be used for research purpose. Inclusion criteria were: being domicile in Ilesha and malignant breast lesion. Exclusion criteria were: being domicile outside Ilesha, benign breast lesion and inability to provide adequate information because of karnofsky performance status. Data obtained were patients’ demographics, clinical and laboratory details of breast cancer burden using American Joint Committee on Cancer (AJCC) staging system and evolution of patient's presentation to health care provider(s). Patients were subdivided into two groups whether they presenting primarily or secondarily for oncological treatment Data obtained were entered into the proforma designed for the study and analysed using Statistical Package for Social Sciences version 22. Descriptive statistics were employed for univariate analysis and, independent samples t test, nonparametric tests and regression analysis for multivariate analysis.

Results

Forty-six patients met the inclusion criteria. They were all females; nine of these patients presented primarily in WGH while the remaining 37 presented secondarily for oncological treatment. Details of their demographic bio- characteristics are as shown in Figure 1 and Table 1. Patient first contact with health care provider distribution (Figure 2) reveals that 60.9% of the sum total of patients presented primarily either at herbal or private hospital. The mean presentation time in weeks for oncological treatment (Figure 3) was longest - 89 weeks - in patients from herbal home and the tumour burden was much advanced (Figure 4) in patients from herbal home and private hospitals. There is a significant difference in presentation time between those that presented primarily (M =11.56 ± 5.21 weeks) and those that presented secondarily (M = 52.56 ± 10.27weeks) for oncological treatment: ( t = -3.56, df = 42.90, two tailed p = 0.001). There is also significant difference in tumour burden between those that presented primarily and those that presented secondarily (U = 78.5, p = 0.011). Table 2 shows care providers’ documentation of patients’ disease., None of the patients from herbal home and mission house had any documentation of their disease and only about half of patients from private hospitals had documentation. In multivariate analysis significant patients’ related factors promoting early presentation to their choice of health care provider (Table 3) are: their matrimonial setting, breast cancer awareness and mode of discovery of breast symptoms and, the significant determinant whether a breast cancer patient will have effective oncological treatment is their first healthcare provider (Table 4).
Figure 1

Summary of enrolled patients

Table 1

Patients’ demographic bio- characteristics

Health care providers
WGHHerbal homeChurchPrivate hospitalHealth centreState hospital
N = 9N = 12N = 2N = 16N = 2N = 5
Educational levelNone080100
Primary422401
Secondary110502
Tertiary410622
Monthly incomeLow892601
Medium020603
High110421
OccupationUnskilled4101602
Artisan111300
Professional410723
Breast cancer awarenessNo51121313
Yes410312
Matrimonial settingMonogamy4421425
2 wives430200
3 wives120000
> 3 wives030000
Marital statusSingle000000
Married5811214
Divorced301110
Widow140301
How discoveredAccidental71021323
Self breast examination210202
Clinical breast examination000100
Nipple discharge000000
Breast discomfort010000
Mammography000000
Figure 2

Patient's distribution at first health care provider's contact

Figure 3

Patients’ first health care providers and mean duration of symptoms before oncological treatment

Figure 4

Distribution of patients’ AJCC staging at first oncological treatment

Table 2

Health care providers’ documentation of patients’ disease

Health care providersTotal
PrimarySecondary
WGHHerbal homeChurchPrivate hospitalHealth centreState hospital
Tissue diagnosis and/or referral note90050115
Referral note only0000246
No referral or tissue diagnosis0122110025
Total 9122162546
Table 3

Determinants of patients’ early presentation to health care providers

FactorsP Value
Age0.599
Educational level0.479
Monthly income0.098
Occupation0.999
Breast cancer awareness0.011
Matrimonial setting0.010
Marital Status0.967
How discovered0.023

Multinominal regression P < 0.05

Table 4

Determinants of effective oncological treatment

FactorsP Value.
Age0.228
Educational level0.089
Monthly income0.128
Occupation0.491
Breast cancer awareness0.649
Matrimonial setting0.796
Marital Status0.925
How discovered0.951
Health care providers at first contact0.001
Health care providers at secondary contact0.413

Linear regression P < 0.05

Summary of enrolled patients Patient's distribution at first health care provider's contact Patients’ first health care providers and mean duration of symptoms before oncological treatment Distribution of patients’ AJCC staging at first oncological treatment Patients’ demographic bio- characteristics Health care providers’ documentation of patients’ disease Determinants of patients’ early presentation to health care providers Multinominal regression P < 0.05 Determinants of effective oncological treatment Linear regression P < 0.05

Discussion

Presentation of breast cancer patients at advanced stage is a major contributor to increasing morbidity and mortality in the developing countries [14, 17]. Reviews from other developing countries (Table 5) highlight reasons for advanced stage presentation from various nations. The variations of causes from nation to nation may be related to their socio-cultural background [18, 19]; therefore, it is important to know the genesis of advanced stage presentation in our environment so as to incorporate this into future breast cancer campaign. Outcome of this study reveals that 19.6% of the patients presented directly in an institution where they had access to oncological treatment while the remaining 80.4% presented primarily at centres with limited resources for breast cancer management with significant difference in the disease burden and presentation time in the two categories of patients. Though, matrimonial setting, breast cancer awareness and mode of discovery of breast symptoms are prominent patients’ related factors promoting early presentation to their first health care provider; the relative importance these factors may be complex and interrelated. The role of matrimonial setting in the choice of health care provider may be related to family belief about breast cancer [20], treaty with a family doctor/spiritualist, and previous family experience of poor outcome of close relatives with breast cancer treated at modern health facility [21]. Though, it is commonly argued that the final health related decision rested with the patient but in African context it is a taboo for a woman to disobey her spouse or close relative even at the risk of her health. Therefore, campaigns directed at early breast cancer presentation should not only be aimed at patients but also at her family. Breast cancer awareness and mode of discovery of breast symptoms as determinants of health care provider presentation reflect patient knowledge of the disease and the disease outcome [22]. Surprisingly, breast cancer patient's level of education is not a determinant of her early presentation to a health care provider in this study (Table 3); probably academic certification may not be synonymous with awareness of a disease and where to obtain appropriate treatment [23]. Thus literacy may not necessarily infer knowledge of a disease and this should be considered during breast cancer sensitization drives.
Table 5

Reviews of presentation of breast cancer patients from developing countries

AuthorsRegionReason for advanced stage presentation
Poum, A., et al. (2013)ThailandHigher family incomeSmokingDelayed referral by health care providers
Ghazali, S. M., et al. (2013MalaysiaNon-practice of breast self examinationMarital status
Alhurishi, S., et al. (2011Middle EastOlder ageLower educational levelLack of family of history of breast cancer
Akhtar, M., et al. (2011).IndiaLack of awareness of breast cancerFinancial constraintsNon referral by general practitioners
Otieno, E. S., et al. (2010).KenyaFear of diagnosisPainlessness of breast pathologyFalse assurance by health providers
Clegg-Lamptey, J., et al. (2009)GhanaPrevious medical consultationsIgnoranceFear of mastectomyHerbal treatmentPrayer/prayer campsFinancial incapability
Reviews of presentation of breast cancer patients from developing countries The result of this study shows the dominant role of a health care provider at first patients’ contact as determinant of effective oncological treatment, though being tag qualified health care personnel is at the prerogative of the government who is the licensing body; unfortunately, 80.4% of the patients presented outside the setting where they can access oncological management. Health care providers’ documentation of patients’ disease in Table 2 may be from misdiagnosis [24], lack of knowledge of the disease and available treatment options [25]. Additionally, it may be from poor judgement about the need for referral to the appropriate health care provider [26, 27]. Improvement in breast cancer outcome in our society can still be accomplished within the existing pluralist health care system through practical interventions that are realistic and efficient [17, 21]. The goal of future research will be to find out what implementation strategies can most effectively guide our pluralist health system reorganization to improve breast cancer outcome. In this regard, there is need for evaluation of appropriate certification and re -accreditation of health care institutions and their permissible scope of enterprise on breast cancer outcome and the effect of disease recognition training in oncology for health care providers operating herbal and convalescence homes on breast cancer presentation. Additionally, there is urgent need for upgrading existing government health care infrastructures and training of personnel in oncology to cope with oncological challenges of years to come.

Conclusion

Presentation of breast cancer patients outside the setting where they can access early and effective oncological treatment seems to forms the basis of advanced stage presentation. Matrimonial setting, breast cancer awareness and mode of discovery of breast symptoms are significant patients’ bio-characteristics that determine their choice of health care provider. These factors should be considered in community breast cancer sensitization drives. Additionally, non oncologist health care providers in our pluralist health system will need re-training in oncology and their scope of enterprise should be properly defined by appropriate government institution.

What is known about this topic

Seventy to eighty percent of breast cancer patients in Nigeria present primarily at oncological centre for treatment with locally advanced or metastatic disease; Breast cancer awareness is the determinant of early presentation to a health care provider; Determinant of effective oncological treatment is patient presentation for treatment.

What this study adds

Only about twenty percent of breast cancer patients in this study present primarily at oncological centre for treatment and about sixty percent of them presented with early breast cancer; Breast cancer awareness, patient's matrimonial setting and mode of discovery of breast symptom are the determinants of early presentation to a health care provider; Determinant of effective oncological treatment is the health care provider at first patient/health care provider contact.
  27 in total

1.  Cultures, subcultures and late presentation with breast cancer.

Authors:  Barbara Potrata
Journal:  Asian Pac J Cancer Prev       Date:  2011

2.  Monitoring the decrease in breast cancer mortality in Europe.

Authors:  Fabio Levi; Cristina Bosetti; Franca Lucchini; Eva Negri; Carlo La Vecchia
Journal:  Eur J Cancer Prev       Date:  2005-12       Impact factor: 2.497

3.  The severity, outcome and challenges of breast cancer in Nigeria.

Authors:  A R K Adesunkanmi; O O Lawal; K A Adelusola; M A Durosimi
Journal:  Breast       Date:  2005-08-08       Impact factor: 4.380

4.  Pattern of presentation and survival of breast cancer in a teaching hospital in north Western Nigeria.

Authors:  Terfa S Kene; Vincent I Odigie; Lazarus Md Yusufu; Bidemi O Yusuf; Sani M Shehu; John T Kase
Journal:  Oman Med J       Date:  2010-04

5.  Recognising symptoms of breast cancer as a reason for delayed presentation in Asian women--the psycho-socio-cultural model for breast symptom appraisal: opportunities for intervention.

Authors:  Nur Aishah Taib; Cheng-Har Yip; Wah-Yun Low
Journal:  Asian Pac J Cancer Prev       Date:  2011

Review 6.  The global breast cancer burden.

Authors:  John R Benson; Ismail Jatoi
Journal:  Future Oncol       Date:  2012-06       Impact factor: 3.404

7.  Pattern of presentation and management of ca breast in developing countries. There is a lot to do.

Authors:  Arshad Mehmood Malik; Rafique Pathan; Noshad Ahmed Shaikh; Jawaid Naeem Qureshi; Khamiso Altaf Hussain Talpur
Journal:  J Pak Med Assoc       Date:  2010-09       Impact factor: 0.781

8.  Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007.

Authors:  Benjamin O Anderson; Cheng-Har Yip; Robert A Smith; Roman Shyyan; Stephen F Sener; Alexandru Eniu; Robert W Carlson; Edward Azavedo; Joe Harford
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

9.  Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city.

Authors:  Adenike O Akhigbe; Vivian O Omuemu
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

10.  Incidence and mortality of female breast cancer in the Asia-Pacific region.

Authors:  Danny R Youlden; Susanna M Cramb; Cheng Har Yip; Peter D Baade
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

View more
  4 in total

1.  Geospatial access predicts cancer stage at presentation and outcomes for patients with breast cancer in southwest Nigeria: A population-based study.

Authors:  Gregory C Knapp; Gavin Tansley; Olalekan Olasehinde; Funmilola Wuraola; Adewale Adisa; Olukayode Arowolo; M O Olawole; Anya M Romanoff; May Lynn Quan; Antoine Bouchard-Fortier; Olusegun I Alatise; T Peter Kingham
Journal:  Cancer       Date:  2020-12-28       Impact factor: 6.860

Review 2.  Prevalence of Themes Linked to Delayed Presentation of Breast Cancer in Africa: A Meta-Analysis of Patient-Reported Studies.

Authors:  Olayide S Agodirin; Isiaka Aremu; Ganiyu A Rahman; Samuel A Olatoke; Halimat J Akande; Adetunji S Oguntola; Olalekan Olasehinde; Sheriff Ojulari; Amarachukwu Etonyeaku; Julius Olaogun; Anya Romanoff
Journal:  JCO Glob Oncol       Date:  2020-05

3.  Impact of Primary Care Delay on Progression of Breast Cancer in a Black African Population: A Multicentered Survey.

Authors:  Olayide Agodirin; Samuel Olatoke; Ganiyu Rahman; Julius Olaogun; Oladapo Kolawole; John Agboola; Olalekan Olasehinde; Aba Katung; Omobolaji Ayandipo; Amarachukwu Etonyeaku; Anthony Ajiboye; Soliu Oguntola; Oluwafemi Fatudimu
Journal:  J Cancer Epidemiol       Date:  2019-08-07

4.  Determinants of Delayed Presentation and Advanced-Stage Diagnosis of Breast Cancer in Africa: A Systematic Review and Meta-Analysis.

Authors:  Olayide Agodirin; Isiaka Aremu; Ganiyu Rahman; Samuel Olatoke; Julius Olaogun; Halimat Akande; Anya Romanoff
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.